» Articles » PMID: 17432990

Long-term Results of Perianal Silicone Injection for Faecal Incontinence

Overview
Journal Colorectal Dis
Specialty Gastroenterology
Date 2007 Apr 17
PMID 17432990
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Perianal injection of bulking agents is a simple method for treating passive faecal incontinence. To date only short-term results of treatment are available. This study is the first to determine the efficacy of silicone biomaterial (PTQ; Uroplasty BV, Geleen, The Netherlands) injection in the long term.

Method: Six patients, median age 53 years at the time of injection with PTQ, were followed up at 61 months. A validated faecal incontinence score, treatment-specific questionnaire and SF-36 health survey questionnaire were completed.

Results: At 61-month follow up one patient had undergone a colostomy for faecal incontinence. In the remaining five patients the incontinence score was little changed: 11 (8-20) vs 13 (9-19) [pre v at 61 months, median (range)]. However, there was a substantial improvement in physical and social function on the SF-36 scores. Satisfaction scores were high at a median 7 of 10 (range: 0-8). Subjectively, three patients were improved; one of these had undergone a further set of injections and one improved after a course of biofeedback. After the follow-up period one of the five patients had a colostomy for recto-vaginal fistula.

Conclusion: The results of perianal injection of PTQ for passive faecal incontinence are variable in the long term. More extensive evaluation in the short term, and possibly repeated treatment, may be required.

Citing Articles

A short- and long-term follow-up study of intersphincteric NASHA Dx implants for fecal incontinence.

Ezra E, Danielsson J, Graf W Tech Coloproctol. 2022; 26(10):813-820.

PMID: 35752984 PMC: 9458585. DOI: 10.1007/s10151-022-02645-6.


Surgical Treatment Alternatives to Sacral Neuromodulation for Fecal Incontinence: Injectables, Sphincter Repair, and Colostomy.

Ivatury S, Wilson L, Paquette I Clin Colon Rectal Surg. 2021; 34(1):40-48.

PMID: 33536848 PMC: 7843951. DOI: 10.1055/s-0040-1714285.


Multicentre observational study of the Gatekeeper for faecal incontinence.

Ratto C, Buntzen S, Aigner F, Altomare D, Heydari A, Donisi L Br J Surg. 2015; 103(3):290-9.

PMID: 26621029 PMC: 5063193. DOI: 10.1002/bjs.10050.


Long-term evaluation of bulking agents for the treatment of fecal incontinence: clinical outcomes and ultrasound evidence.

Guerra F, La Torre M, Giuliani G, Coletta D, Amore Bonapasta S, Velluti F Tech Coloproctol. 2014; 19(1):23-7.

PMID: 25381455 DOI: 10.1007/s10151-014-1236-7.


Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence.

Mellgren A, Matzel K, Pollack J, Hull T, Bernstein M, Graf W Neurogastroenterol Motil. 2014; 26(8):1087-94.

PMID: 24837493 PMC: 4371654. DOI: 10.1111/nmo.12360.